These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9035165)

  • 1. HLA-DR7 predicts the response to alkylating agents in steroid-sensitive nephrotic syndrome.
    Konrad M; Mytilineos J; Ruder H; Opelz G; Schärer K
    Pediatr Nephrol; 1997 Feb; 11(1):16-9. PubMed ID: 9035165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unfavorable response to cyclophosphamide in steroid-dependent nephrotic syndrome.
    Kemper MJ; Altrogge H; Ludwig K; Timmermann K; Müller-Wiefel DE
    Pediatr Nephrol; 2000 Aug; 14(8-9):772-5. PubMed ID: 10955925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of the idiopathic nephrotic syndrome.
    Kleinknecht C; Broyer M; Jarde O; Guillot M
    Paediatrician; 1981; 10(5-6):382-99. PubMed ID: 7036046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linear growth of children with nephrotic syndrome: effect of alkylating agents.
    Padilla R; Brem AS
    Pediatrics; 1989 Sep; 84(3):495-9. PubMed ID: 2771553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid-responsive relapsing nephrotic syndrome associated with early diabetic glomerulopathy in a child.
    Peces R; Riera JR; López Larrea C; Alvarez J
    Nephron; 1987; 46(1):78-82. PubMed ID: 3600916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-corticosteroid treatment for nephrotic syndrome in children.
    Durkan A; Hodson E; Willis N; Craig J
    Cochrane Database Syst Rev; 2001; (4):CD002290. PubMed ID: 11687155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K
    J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide in steroid-sensitive nephrotic syndrome: outcome and outlook.
    Vester U; Kranz B; Zimmermann S; Hoyer PF
    Pediatr Nephrol; 2003 Jul; 18(7):661-4. PubMed ID: 12750975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicentre randomized controlled trial.
    Ponticelli C; Edefonti A; Ghio L; Rizzoni G; Rinaldi S; Gusmano R; Lama G; Zacchello G; Confalonieri R; Altieri P
    Nephrol Dial Transplant; 1993; 8(12):1326-32. PubMed ID: 8159300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
    Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Verification of indications for kidney biopsy in children with steroid-dependent nephrotic syndrome].
    Idczak-Nowicka E; Ksiazek J; Kryński J; Wyszyńska T
    Pediatr Pol; 1996 Aug; 71(8):679-83. PubMed ID: 8927471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of subsequent relapse in children with steroid-sensitive nephrotic syndrome.
    Takeda A; Takimoto H; Mizusawa Y; Simoda M
    Pediatr Nephrol; 2001 Nov; 16(11):888-93. PubMed ID: 11685595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up in children with steroid-resistant nephrotic syndrome.
    Besbas N; Topaloglu R; Saatci O; Bakkaloglu A
    Clin Pediatr (Phila); 1992 May; 31(5):283-8. PubMed ID: 1582094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into treatment of nephrotic syndrome in children.
    Wang X; Xu H
    Contrib Nephrol; 2013; 181():119-30. PubMed ID: 23689574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of chlorambucil therapy in steroid-dependent and cyclophosphamide-resistant children with nephrosis.
    Elzouki AY; Jaiswal OP
    Pediatr Nephrol; 1990 Sep; 4(5):459-62. PubMed ID: 2242305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of idiopathic nephrotic syndrome with cyclosporin A].
    Ariceta Iraola G; Rodríguez Soriano J; Vallo Boado A; Quintela Pérez MJ; Oliveros Pérez R
    An Esp Pediatr; 1997 Sep; 47(3):273-8. PubMed ID: 9499280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-corticosteroid treatment for nephrotic syndrome in children.
    Hodson EM; Willis NS; Craig JC
    Cochrane Database Syst Rev; 2008 Jan; (1):CD002290. PubMed ID: 18254005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous remissions in frequently relapsing and steroid dependent idiopathic nephrotic syndrome.
    Wingen AM; Müller-Wiefel DE; Schärer K
    Clin Nephrol; 1985 Jan; 23(1):35-40. PubMed ID: 3978880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence.
    Arbeitsgemeinschaft für Pädiatrische Nephrologie
    N Engl J Med; 1982 Feb; 306(8):451-4. PubMed ID: 7035953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorambucil treatment of frequently relapsing nephrotic syndrome.
    Grupe WE; Makker SP; Ingelfinger JR
    N Engl J Med; 1976 Sep; 295(14):746-9. PubMed ID: 958261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.